Related Product Information
This protocol is to be used as a supplement to the CytoTune®-iPS 2.0 Sendai Reprogramming Kit User Guide (MAN0009378). Please refer to the user guide for general descriptions of the CytoTune®-iPS 2.0 Sendai Reprogramming Kit and associated methodologies.
- CytoTune® -iPS 2.0 Sendai Reprogramming Kit (Cat. nos. A16517 and A16518)
Note: For successful reprogramming, you need all three reprogramming vectors.
- Peripheral blood mononuclear cells (PBMCs) to reprogram
Note: You can use PBMCs extracted from blood by a conventional method (i.e., Ficoll-Paque® purification) or frozen PBMCs.
- StemPro®-34 SFM Medium (Cat. no. 10639-011)
- L-Glutamine (Cat. no. 25030-081)
- SCF (c-kit Ligand), Recombinant Human (Cat. no. PHC2111)
- FLT-3 Ligand, Recombinant Human (Cat. no. PHC9414)
- IL-3, Recombinant Human (Cat. no. PHC0034)
- IL-6, Recombinant Human (Cat. no. PHC0065)
- Vitronectin (VTN-N) Recombinant Human Protein, Truncated (Cat. no. A14700)
- Geltrex® LDEV-Free hESC-qualified Reduced Growth Factor Basement Membrane Matrix (Cat. no. A1413301) (optional)
- DPBS Without Calcium or Magnesium (Cat. no. 14190-144)
- Sterile cell culture hood (i.e. biosafety cabinet) equipped with a stereo microscope
- Inverted microscope
- Incubator set at 37°C, 5% CO2
- Water bath set at 37°C
- Sterile serological pipettes (5-mL, 10-mL)
- Centrifuge (swinging bucket rotor)
- 15-mL centrifuge tubes
- Sterile, round-bottom centrifuge tubes (e.g., Falcon 352054)
- 6-well, 12-well, and 24-well tissue culture-treated plates
- 25-gauge 1½-inch needle
 StemPro®-34 SFM Medium: For human ex vivo tissue and cell culture processing applications. CAUTION: When used as a medical device, Federal Law restricts this device to sale by or on the order of a physician.
- To maintain sterile culture conditions, carry out all of the procedures using sterile laboratory practices in a laminar flow hood.
- For successful reprogramming, transduce your cells using all three reprogramming vectors.
Note: For successful reprogramming, all four Yamanaka factors (i.e., Oct4, Sox2, Klf4, and c-Myc) need to be expressed in your host cell.
- The titer of each CytoTune®-iPS 2.0 Sendai reprogramming vector is lot-dependent. For the specific titer of your vectors, refer to the Certificate of Analysis (CoA) available on our website. Go to www.lifetechnologies.com/cytotune and search for the CoA by product lot number, which is printed on the vial.
- Viral titers can decrease dramatically with each freeze/thaw cycle. Avoid repeated freezing and thawing of your reprogramming vectors. Viral titer is not guaranteed for kits that have been refrozen and thawed.
- Prior to starting, ensure that the media are equilibrated to 37°C and appropriately gassed.
- For positive control, we recommend performing a reprogramming experiment with human neonatal foreskin fibroblast cells (strain BJ; ATCC no. CRL2522). Note that experimental conditions may vary among target cells and need to be optimized for each cell type. The example given in the following protocol does not guarantee the generation of iPSCs for all cell types.
SCF (c-kit Ligand), FLT-3 Ligand, -IL-3 and IL-6 Stock Solutions
SCF (c-kit Ligand), FLT-3 Ligand, IL-3 and IL-6 are supplied lyophilized. Prepare stock solutions as described in their specific product inserts and store small aliquots frozen. Thaw at time of use.
PBMC Medium (for 500 mL complete medium)
PBMC medium consists of complete StemPro®-34 medium supplemented with the appropriate cytokines. Follow the procedure below to prepare 500 mL of complete PBMC medium.
- Thaw the frozen StemPro®-34 Nutrient Supplement at 4°C overnight.
- After thawing, mix the supplement well by gently inverting the vial a couple of times, and then aseptically transfer the entire contents of the vial to the bottle of StemPro®-34 SFM. Swirl the bottle to mix and to obtain a homogenous complete medium.
- Aseptically add L-Glutamine to a final concentration of 2 mM (5 mL of 200 mM L-Glutamine to 500 mL of medium).
- The complete medium (without cytokines) has a shelf life of 30 days when stored at 2–8°C, in the dark.
- Add the following cytokines to the indicated final concentration on the day of use:
Essential 8® Medium (for 500 mL of complete medium)
- Thaw frozen Essential 8® Supplement at 2-8°C overnight before using it to prepare complete medium. Do not thaw the frozen supplement at 37°C.
- Mix the thawed supplement by gently inverting the vial a couple of times, remove 10 mL from the bottle of Essential 8® Basal Medium, and then aseptically transfer the entire contents of the Essential 8® Supplement to the bottle of Essential 8® Basal Medium. Swirl the bottle to mix and to obtain 500 mL of homogenous complete medium.
- Complete Essential 8® Medium can be stored at 2-8°C for up to 2 weeks. Before use, warm complete medium required for that day at room temperature until it is no longer cool to the touch. Do not warm the medium at 37°C.
The following protocol has been optimized for peripheral blood mononuclear cells (PBMCs) isolated by centrifugation through a Ficoll-Paque® density gradient and frozen in FBS and DMSO-containing medium. We recommend that you optimize the protocol for your cell type.
Day –4: Seed PBMCs
- 4 days before transduction, thaw PBMCs and gently transfer the cells into a 15-mL conical tube. Slowly (dropwise) add 5–10 mL pre-warmed complete PBMC medium (complete StemPro®-34 serum-free medium containing the appropriate cytokines; aliquot the cytokines and add fresh daily) to the cell suspension. Remove an aliquot of cells to count and determine cell viability.
- Centrifuge the cell suspension at 200 × g for 10 minutes, discard the supernatant, and resuspend the cells in complete PBMC medium to 500,000 cells/mL.
- Add 1 mL per well to the middle section of a 24-well plate to prevent excessive evaporation of the medium during incubation.
- Incubate the cells in a 37°C incubator with a humidified atmosphere of 5% CO2.
- Count the cells daily, gently remove 0.5 mL of the medium, and add 0.5 mL of fresh complete PBMC medium trying not to disturbing the cells. If cells are removed in the 0.5 mL, centrifuge the cell suspension for 10 minutes at 200 × g, discard the supernatant, and resuspend the cells in 0.5 mL fresh medium. Note: Some cell death is generally observed the first day after the thaw. Some cells may adhere to the surface of the tissue culture plate. Proceed with the cells in suspension. Cells will not proliferate, but should maintain stable cell numbers after the first day.
- Count the number of cells using a hemocytometer or the Countess® Automated Cell Counter to determine the viability and total number of cells.
Note: Cells may have decreased in number. Proceed with transduction using the live cell count.
- Harvest the cells and bring to 2.5 × 105–5 × 105 cells/mL for transduction. We generally recommend transducing 300,000 cells per sample. Add the appropriate volume of cells to be transduced to a sterile, round-bottom centrifuge tube.
- Remove one set of CytoTune®-iPS 2.0 Sendai reprogramming tubes from the –80°C storage. Thaw each tube one at a time by first immersing the bottom of the tube in a 37°C water bath for 5–10 seconds, and then removing the tube from the water bath and allowing it to thaw at room temperature. Once thawed, briefly centrifuge the tube and place it immediately on ice.
- Transduce the cells by adding the Klf4, Oct4, and Sox2 (KOS) virus and the c-Myc virus at an MOI of 5 (KOS MOI=5, hc-Myc MOI=5) and the Klf4 virus at an MOI of 3 (hKlf4 MOI=3) in a total volume of 1 mL. Transduction and reprogramming efficiencies are greatly increased by a centrifugation step at this point. Place the cap on the centrifuge tube and wrap with Parafilm® sealing film. Centrifuge at 2250 rpm for 30 minutes at room temperature. When the centrifugation is complete, resuspend the pellet in the same medium containing the virus and add an additional 1 mL of complete PBMC media to the well and plate in a 12-well tissue culture plate and incubate overnight at 37°C. Note: We recommend initially performing the transductions with MOIs of 5-5 and 3 as specified above. This MOI can be optimized for your application.
Day 1: Remove CytoTune® Sendai virus and culture cells
- The next day, remove the cells and medium from the culture plate and transfer to a 15-mL centrifuge tube. Rinse the well gently with 1 mL of medium to ensure most of the cells are harvested.
- Remove the CytoTune® Sendai viruses by centrifuging the cells at 200 × g for 10 minutes, aspirating the supernatant, and resuspending the cells in 0.5 mL of complete PBMC medium in a 24-well plate.
Note: The cells may have drastic cell death (>60%); continue with the protocol using live cell count. For the first 48 hours, view the cells under the microscope for changes in cell morphology as a validation of transduction. Expect large, aggregated cells.
- Culture the cells at 37°C for 2 days.
Note: While the cells are incubating, prepare at least two wells of a 6-well plate with either Geltrex® matrix or vitronectin coating for each well of transduced cells. Higher reprogramming efficiencies have been observed on Geltrex® matrix-coated plates, but following this protocol we have obtained reprogramming efficiencies of 0.8% on vitronectin-coated plates. See Coating Culture Vessels with Vitronectin and Coating Culture Vessels with Geltrex® Matrix instructions near the end of this protocol.
Day 3: Plate cells on Vitronectin- or Geltrex® matrix-coated culture dishes
- Count the cells using the desired method (e.g., Countess® Automated Cell Counter) and seed the Geltrex® matrix- or vitronectin-coated culture dishes with 10,000 and 50,000 live cells per dish in 2 mL of complete StemPro®-34 medium without the cytokines. Incubate the cells at 37°C. Plate any excess cells onto a Geltrex® matrix- or vitronectin-coated culture dish or harvest for later RNA analysis as necessary.
Day 3–6: Replace spent medium
- Every other day, gently remove 1 mL (half) of the spent medium from the cells and replace it with 1 mL of fresh complete StemPro®-34 medium without cytokines working with care to not disturb the cells.
Day 7: Start transition to Essential 8® medium
- Prepare 500 mL Essential 8® medium as described above.
- Remove 1 mL (half) of StemPro®-34 medium from the cells and replace it with 1 mL of Essential 8® medium to start the transition of the cells to the new culture medium.
Day 8 to 28: Feed and monitor the cells
- 24 hours later (day 8), change the full volume of medium to Essential 8® medium, and replace the spent medium everyday thereafter.
- Starting on day 8, observe the plates every other day under a microscope for the emergence of cell clumps indicative of transformed cells.
- Day 15 to 21 after transduction, colonies should have grown to an appropriate size for transfer. Manually pick colonies and transfer them onto prepared 12- or 24-well Vitronectin- or Geltrex® matrix-coated culture plates.
Day –3 to –1: Observe cells and add fresh medium
Day 0: Count cells and perform transduction
Instructions for coating a 6-well culture plate with vitronectin at a coating concentration of 0.5 μg/cm2 are provided below.
- Upon receipt, thaw the vial of vitronectin at room temperature and prepare 60-μL aliquots of vitronectin in polypropylene tubes. Freeze the aliquots at –80°C or use immediately.
- To coat the wells of a 6-well plate, remove a 60-μL aliquot of vitronectin from –80°C storage and thaw at room temperature. You will need one 60-μL aliquot per 6-well plate.
- Add 60 μL of thawed vitronectin into a 15-mL conical tube containing 6 mL of sterile DPBS without Calcium and Magnesium (Cat. no. 14190) at room temperature. Gently resuspend by pipetting the vitronectin dilution up and down.
Note: This results in a working concentration of 5 μg/mL (i.e., a 1:100 dilution).
- Add 1 mL of the diluted vitronectin solution to each well of a 6-well plate (refer to the table below for the recommended volumes for other culture vessels). When used to coat a 6-well plate (10 cm2/well) at 1 mL/well, the final concentration will be 0.5 μg/cm2.
- Incubate the coated plates at room temperature for 1 hour.
Note: The culture vessel can now be used or stored at 2–8°C wrapped in laboratory film for up to a week. Do not allow the vessel to dry. Prior to use, pre-warm the culture vessel to room temperature for at least 1 hour.
- Aspirate the vitronectin solution and discard. It is not necessary to rinse off the culture vessel after the removal of vitronectin. Cells can be plated directly onto the vitronectin-coated culture vessels.
|Culture vessel||Surface area||Volume of diluted vitronectin solution|
|6-well plate||10 cm2/well||1.0 mL/well|
|12-well plate||4 cm2/well||0.4 mL/well|
|24-well plate||2 cm2/well||0.2 mL/well|
|35-mm dish||10 cm2||1.0 mL|
|60-mm dish||20 cm2||2.0 mL|
|100-mm dish||60 cm2||6.0 mL|
|T-25 flask||25 cm2||2.5 mL|
|T-75 flask||75 cm2||7.5 mL|
- Thaw a 5-mL bottle of Geltrex® LDEV-Free hESC-Qualified Reduced Growth Factor Basement Membrane Matrix at 2–8°C overnight.
- To create working stocks, dilute an aliquot of Geltrex® matrix solution 1:50 with cold DMEM on ice.
Note: An optimal dilution of the Geltrex® matrix solution may need to be determined for each cell line. Try various dilutions from 1:30 to 1:100.
- Quickly cover the whole surface of each culture dish with the Geltrex® matrix solution (see table below).
- Incubate the dishes in a 37°C, 5% CO2 incubator for 1 hour.
- Geltrex® matrix-coated culture dishes can now be used or stored at 2–8°C for up to a week. Do not allow dishes to dry.
- Aspirate the diluted Geltrex® matrix solution from the culture dish and discard. You do not need to rinse off the Geltrex® matrix solution from the culture dish after removal. Cells can now be plated directly onto the Geltrex® matrix-coated culture dish.
|Culture vessel||Surface area||Volume of Geltrex® matrix dilution
|6-well plate||10 cm2/well||1.5 mL/well|
|12-well plate||4 cm2/well||750 µL/well|
|24-well plate||2 cm2/well||350 µL/well|
|35-mm dish||10 cm2||1.5 mL|
|60-mm dish||20 cm2||3.0 mL|
|100-mm dish||60 cm2||6.0 mL|